Top Markets
#1 DogBull DogBull +108.16%
#2 MarsCoin MarsCoin +54.04%
#3 ADO Protocol ADO Protocol +52.32%
#4 Siacoin Siacoin +43.46%
#5 Ontology Gas Ontology Gas +24.98%
#6 Apertum Apertum +19.55%
#7 Falcon Finance Falcon Finance +19.31%
#8 Useless Coin Useless Coin +16.90%
#9 Nockchain Nockchain +16.81%
#10 UnifAI Network UnifAI Network +16.48%
Coin of the day
DogBull DogBull
Innstillinger
Språk
NORSK
Valuta
USD
Tema
BioAge Labs Inc. BioAge Labs Inc.

BioAge Labs Inc.

BIOA
Rangering i aksjer #15446
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops... BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.
Aksjekurs
$9.42
Markedsverdi
$354.69M
Endring (1 dag)
-0.83%
Endring (1 år)
91.09%
Land
US
Handel BioAge Labs Inc. (BIOA)

Kategori

Healthcare
P/S-forhold for BioAge Labs Inc. (BIOA)
P/S-forhold per 2026 TTM: 0
Ifølge BioAge Labs Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for BioAge Labs Inc. fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.95 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
12.19 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.75 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
24.99 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH